Longboard Pharmaceuticals Top Insiders
LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Longboard Pharmaceuticals employs about 50 people. The company is managed by 11 executives with a total tenure of roughly 117 years, averaging almost 10.0 years of service per executive, having 4.55 employees per reported executive. Assessment of Longboard Pharmaceuticals' management performance can provide insight into the firm performance.
Longboard |
Longboard Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3072) % which means that it has lost $0.3072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4666) %, meaning that it created substantial loss on money invested by shareholders. Longboard Pharmaceuticals' management efficiency ratios could be used to measure how well Longboard Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Longboard Pharmaceuticals Workforce Comparison
Longboard Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,662. Longboard Pharmaceuticals holds roughly 50.0 in number of employees claiming about 3% of equities under Health Care industry.
Longboard Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Longboard Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Longboard Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Longboard Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Longboard Pharmaceuticals Notable Stakeholders
A Longboard Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Longboard Pharmaceuticals often face trade-offs trying to please all of them. Longboard Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Longboard Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dewey McLin | VP Affairs | Profile | |
Nuggehally Srinivas | VP Pharmacometrics | Profile | |
Anne Danks | VP Development | Profile | |
Jodi Parsons | VP Affairs | Profile | |
Chadwick MPH | Executive Operations | Profile | |
Steven JD | Head Counsel | Profile | |
Randall MD | Executive Officer | Profile | |
Megan Knight | Head Relations | Profile | |
Marco Peters | VP Science | Profile | |
Kevin Lind | CEO and President | Profile | |
Gus Cardenas | VP Assurance | Profile |
About Longboard Pharmaceuticals Management Performance
The success or failure of an entity such as Longboard Pharmaceuticals often depends on how effective the management is. Longboard Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Longboard management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Longboard management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.
Longboard Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Longboard Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Longboard Pharmaceuticals within its industry.Longboard Pharmaceuticals Manpower Efficiency
Return on Longboard Pharmaceuticals Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 4.9M | |
Working Capital Per Employee | 808.9K | |
Working Capital Per Executive | 3.7M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |